|
Uptake of Protein Toxins Acting Inside Cells |
|
|
1 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Introduction and Brief Description of Relevant Toxins |
|
|
1 | (3) |
|
Binding to Cell-Surface Receptors |
|
|
4 | (1) |
|
|
5 | (2) |
|
Retrograde Vesicular Transport |
|
|
7 | (1) |
|
Transport to the Golgi Apparatus |
|
|
7 | (1) |
|
Transport to the Endoplasmic Reticulum |
|
|
7 | (1) |
|
Translocation to the Cytosol |
|
|
8 | (3) |
|
|
8 | (1) |
|
|
9 | (1) |
|
|
9 | (2) |
|
Stability of Toxins in the Cytosol |
|
|
11 | (1) |
|
Translocation of Fusion Proteins |
|
|
12 | (9) |
|
|
14 | (7) |
|
Common Features of ADP-Ribosyltransferases |
|
|
21 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 | (1) |
|
The Well-Characterized Toxins |
|
|
21 | (5) |
|
A Common Structure for the Catalytic Site |
|
|
26 | (7) |
|
|
27 | (2) |
|
|
29 | (1) |
|
|
30 | (3) |
|
Other Bacterial Toxins with ADP-Ribosylating Activity |
|
|
33 | (2) |
|
Eukaryotic Mono-ADP-Ribosyltransferases |
|
|
35 | (2) |
|
|
37 | (8) |
|
|
39 | (6) |
|
Diphtheria Toxin and the Diphtheria-Toxin Receptor |
|
|
45 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 | (1) |
|
|
45 | (6) |
|
Synthesis of Diphtheria Toxin |
|
|
45 | (1) |
|
Toxicity of Diphtheria Toxin |
|
|
46 | (2) |
|
Structure and Function of Diphtheria Toxin |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
Sensitivity to Diphtheria Toxin |
|
|
50 | (1) |
|
The Diphtheria-Toxin Receptor |
|
|
51 | (16) |
|
Identification of the Diphtheria-Toxin-Receptor Protein |
|
|
51 | (1) |
|
Cloning of the Diphtheria-Toxin-Receptor Gene |
|
|
52 | (1) |
|
The Structure and Function of the Diphtheria-Toxin Receptor |
|
|
53 | (2) |
|
Molecules Associated with the Diphtheria-Toxin Receptor |
|
|
55 | (1) |
|
|
55 | (2) |
|
|
57 | (1) |
|
Receptor and Toxin Entry Process |
|
|
58 | (1) |
|
Physiological Role of the Diphtheria-Toxin Receptor |
|
|
59 | (1) |
|
|
59 | (1) |
|
Juxtacrine Growth Regulator |
|
|
59 | (1) |
|
Conversion of the Membrane-anchored Form to the Soluble Form |
|
|
60 | (1) |
|
|
61 | (6) |
|
Pseudomonas aeruginosa Exotoxin A: Structure/Function, Production, and Intoxication of Eukaryotic Cells |
|
|
67 | (24) |
|
|
|
|
|
|
67 | (4) |
|
|
68 | (2) |
|
|
70 | (1) |
|
Production of ETA by the Bacterial Cell |
|
|
71 | (5) |
|
Characterization of the toxA Structural Gene |
|
|
71 | (1) |
|
Environmental and Temporal Signals Affecting ETA Production |
|
|
71 | (1) |
|
Regulation of ETA Production |
|
|
72 | (3) |
|
Secretion from the Bacterial Cell |
|
|
75 | (1) |
|
Intoxication of Eukaryotic Cells |
|
|
76 | (15) |
|
Binding to a Specific Receptor on the Eukarvotic Cell Surface and Internalization by Receptor-Mediated Endocytosis |
|
|
77 | (2) |
|
Activation by Proteolytic Cleavage and/or a Conformational Change |
|
|
79 | (1) |
|
Removal of a Terminal Lysine Residue and Translocation into the Cytosol |
|
|
80 | (1) |
|
ADP-Ribosylation of Elongation Factor 2 |
|
|
80 | (2) |
|
|
82 | (9) |
|
Diphtheria-Toxin-Based Fusion-Protein Toxins Targeted to the Interleukin-2 Receptor: Unique Probes for Cell Biology and a New Therapeutic Agent for the Treatment of Lymphoma |
|
|
91 | (18) |
|
|
|
|
|
|
|
|
|
|
91 | (1) |
|
Diphtheria-Toxin-Based Cytokine Fusion Proteins |
|
|
91 | (4) |
|
DAB389IL-2 as a Novel Biological Probe for Cell Biology |
|
|
95 | (2) |
|
Pre-Clinical Characterization of DAB486IL-2 and DAB389IL-2 |
|
|
97 | (1) |
|
Clinical Evaluation of DAB486IL-2 and DAB389IL-2 |
|
|
98 | (11) |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
Cutaneous T-Cell Lymphoma |
|
|
102 | (2) |
|
|
104 | (5) |
|
Structure and Function of Cholera Toxin and Related Enterotoxins |
|
|
109 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109 | (1) |
|
Three-Dimensional Structures of Holotoxins |
|
|
110 | (2) |
|
Toxin Assembly and Secretion |
|
|
112 | (1) |
|
Design of Assembly Antagonists |
|
|
113 | (1) |
|
Cell-Surface-Receptor Recognition |
|
|
113 | (2) |
|
Design of Receptor Anatagonists |
|
|
115 | (1) |
|
|
115 | (2) |
|
|
117 | (3) |
|
Substrates, Artificial Substrates, and Inhibitors |
|
|
117 | (2) |
|
|
119 | (1) |
|
|
120 | (5) |
|
|
125 | (8) |
|
|
125 | (8) |
|
Mechanism of Cholera Toxin Action: ADP-Ribosylation Factors as Stimulators of Cholera Toxin-Catalyzed ADP-Ribosylation and Effectors in Intracellular Vesicular Trafficking Events |
|
|
133 | (34) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133 | (2) |
|
|
135 | (2) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
|
|
137 | (15) |
|
|
137 | (1) |
|
Biochemical Characterization of ARFs |
|
|
138 | (1) |
|
|
139 | (1) |
|
The Primary Structures of ARFs |
|
|
139 | (1) |
|
The Tertiary Structures of ARFs |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
141 | (2) |
|
|
143 | (2) |
|
Molecules that Regulate ARF Function: GEPs and GAPs |
|
|
145 | (1) |
|
ARF Guanine Nucleotide-Exchange Proteins |
|
|
145 | (2) |
|
ARF GTPase-Activating Proteins |
|
|
147 | (2) |
|
Other ARF-Interacting Molecules |
|
|
149 | (1) |
|
|
149 | (1) |
|
|
150 | (1) |
|
|
150 | (1) |
|
ARFs' Role in Vesicular Trafficking Events |
|
|
150 | (1) |
|
Subcellular Localization of ARF |
|
|
151 | (1) |
|
|
152 | (15) |
|
|
152 | (15) |
|
Pertussis Toxin: Structure-Function Relationship |
|
|
167 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
167 | (1) |
|
The Receptor-Binding Activity of PTX |
|
|
168 | (2) |
|
Membrane Translocation of PTX |
|
|
170 | (5) |
|
The Enzymatic Activity of S1 |
|
|
175 | (1) |
|
The Enzyme Mechanism of S1-Catalyzed ADP-Ribosylation |
|
|
176 | (2) |
|
The Catalytic Residues of PTX |
|
|
178 | (2) |
|
|
180 | (2) |
|
|
182 | (5) |
|
|
182 | (5) |
|
Pertussis Toxin as a Pharmacological Tool |
|
|
187 | (20) |
|
|
|
|
|
|
187 | (2) |
|
Molecular Aspects of PT Activity on G Proteins |
|
|
189 | (6) |
|
|
189 | (1) |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
191 | (2) |
|
PT as a Tool with which to Study G-Protein-Subunit Composition |
|
|
193 | (2) |
|
Functional Consequences of PT Activity |
|
|
195 | (12) |
|
PT-Affecting Receptor-G-Protein-Effector Coupling |
|
|
195 | (2) |
|
PT-Affecting Receptor-Independent Activation of G Proteins |
|
|
197 | (1) |
|
Use of PT in Studying Cellular Signal Transduction |
|
|
198 | (1) |
|
Appendix: Experimental Protocols for Using PT |
|
|
199 | (1) |
|
Source of PT and Preparation of Solutions |
|
|
199 | (1) |
|
Treatment of Mammalian Cell Cultures with PT |
|
|
199 | (1) |
|
Activation of PT for in Vitro ADP-Ribosylation |
|
|
199 | (1) |
|
ADP-Ribosylation of Cell-Membrane Proteins by PT |
|
|
200 | (1) |
|
ADP-Ribosylation of Isolated Proteins by PT |
|
|
200 | (1) |
|
Preparation of Samples for Sodium Dodecyl Sulfate Polyacrylamide-Gel Electrophoresis |
|
|
200 | (1) |
|
Cleavage of ADP-Ribose from Gα Subunits |
|
|
201 | (1) |
|
|
201 | (6) |
|
Clostridium Botulinum C3 Exoenzyme and C3-Like Transferases |
|
|
207 | (28) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
207 | (1) |
|
Origin and Purification of C3 Exoenzymes |
|
|
207 | (2) |
|
|
207 | (1) |
|
Purification of C3 Exoenzymes |
|
|
208 | (1) |
|
Genetics of C3 and C3-Like Exoenzymes |
|
|
209 | (1) |
|
Structure-Function Analysis of C3 Exoenzymes |
|
|
210 | (2) |
|
ADP-Ribosyltransferase Activity |
|
|
212 | (6) |
|
|
212 | (1) |
|
Regulation by Detergents and Divalent Cations |
|
|
212 | (1) |
|
Rho Proteins as Substrates for C3 |
|
|
213 | (2) |
|
Functional Consequences of the ADP-Ribosylation of Rho |
|
|
215 | (3) |
|
Application of C3-Like Exoenzymes as Tools |
|
|
218 | (1) |
|
Cellular Effects of C3 Exoenzymes |
|
|
219 | (5) |
|
Effects of C3 on Cell Morphology and Actin Structure |
|
|
219 | (3) |
|
Effects of C3 on Cell-Cell Contacts |
|
|
222 | (1) |
|
Effects of C3 on Endocytosis and Phagocytosis |
|
|
223 | (1) |
|
Effects of C3 on Cell Signalling not Directly Involving the Actin Cytoskeleton |
|
|
223 | (1) |
|
Phospholipase D and PIP5 Kinase |
|
|
223 | (1) |
|
Signalling to the Nucleus and Gene Transcription |
|
|
224 | (1) |
|
|
224 | (11) |
|
|
225 | (10) |
|
Pseudomonas aeruginosa Exoenzyme S, a Bifunctional Cytotoxin Secreted by a Type-III Pathway |
|
|
235 | (18) |
|
|
|
|
|
|
|
|
|
|
235 | (1) |
|
Initial Biochemical Characterization of ExoS |
|
|
236 | (1) |
|
Genetic Analysis of the Structural Genes Encoding ExoS |
|
|
236 | (1) |
|
ExoS Requires FAS to Express ADP-Ribosyltransferase Activity |
|
|
237 | (1) |
|
Molecular Properties of ExoS |
|
|
237 | (2) |
|
Secretion of ExoS via a Type-III Secretion Pathway |
|
|
239 | (1) |
|
Regulation of exoS Regulation Expression |
|
|
240 | (1) |
|
The Carboxyl Terminus of ExoS Comprises the ADP-Ribosyltransferase Domain |
|
|
240 | (4) |
|
Functional Mapping of ExoS |
|
|
240 | (1) |
|
ExoS is a Biglutamic-Acid Transferase |
|
|
240 | (2) |
|
ExoS can ADP-Ribosylate Numerous Proteins |
|
|
242 | (1) |
|
ExoS ADP-Ribosylates Ras at Multiple Arginine Residues |
|
|
243 | (1) |
|
ExoS is a Bifunctional Cytotoxin |
|
|
244 | (2) |
|
Cytotoxic Properties of ExoS |
|
|
245 | (1) |
|
The Amino Terminus of ExoS Stimulates Rho-Dependent Depolymerization of Actin |
|
|
245 | (1) |
|
The Carboxyl Terminus of ExoS is an ADP-Ribosyltransferase that is Cytotoxic to Cultured Cells |
|
|
246 | (1) |
|
Mechanism for the Inhibition of Ras-Mediated Signal Transduction by ExoS |
|
|
246 | (1) |
|
Functional and Sequence Relationship Between ExoS and the Vertebrate ADP-Ribosyltransferases |
|
|
247 | (1) |
|
|
248 | (5) |
|
|
248 | (5) |
|
Structure and Function of Actin-Adenosine-Diphosphate-Ribosylating Toxins |
|
|
253 | (22) |
|
|
|
|
|
|
253 | (1) |
|
Clostridium Botulinum C2 Toxin |
|
|
253 | (9) |
|
Actin-ADP-Ribosylating Toxin of C. Botulinum Types C and D |
|
|
253 | (1) |
|
Molecular Structure of Botulinum C2 Toxin |
|
|
254 | (2) |
|
Molecular Functions of Two Components of C2 Toxin |
|
|
256 | (1) |
|
ADP-Ribosylation of Actin by C2 Toxin |
|
|
257 | (1) |
|
ADP-Ribosylation of Intracellular Actin of Cultured Cells |
|
|
258 | (2) |
|
ADP-Ribosylation of Purified Actin |
|
|
260 | (2) |
|
C. Perfringens Iota Toxin |
|
|
262 | (3) |
|
Actin-ADP-Ribosylating Toxin of C. Perfringens Type E |
|
|
262 | (1) |
|
Molecular Structure and Function |
|
|
263 | (2) |
|
|
265 | (1) |
|
Actin-ADP-Ribosylating Toxin of C. Spiroforme |
|
|
265 | (1) |
|
Molecular Structure and Function |
|
|
265 | (1) |
|
|
266 | (2) |
|
Actin-ADP-Ribosylating Toxin of C. Difficile |
|
|
266 | (1) |
|
Molecular Structure and Function |
|
|
266 | (2) |
|
|
268 | (7) |
|
|
269 | (6) |
|
Molecular Biology of Actin-ADP-Ribosylating Toxins |
|
|
275 | (32) |
|
|
|
|
|
|
275 | (1) |
|
Bacteria Producing Actin-ADP-Ribosylating Toxins |
|
|
276 | (1) |
|
|
276 | (1) |
|
|
276 | (1) |
|
|
277 | (1) |
|
|
277 | (1) |
|
Families of Actin-ADP-Ribosylating Toxins |
|
|
277 | (5) |
|
|
278 | (1) |
|
|
279 | (1) |
|
Relatedness Between C2-Toxin and Iota-Toxin Families |
|
|
279 | (3) |
|
Actin-ADP-Ribosylating-Toxin Genes and Predicted Molecules |
|
|
282 | (2) |
|
Iota-Toxin Genes and Iota-Toxin Proteins |
|
|
282 | (1) |
|
C. Spiroforme Toxin and CDT Genes |
|
|
283 | (1) |
|
C. Spiroforme Toxin and CDT Proteins |
|
|
283 | (1) |
|
C2-Toxin Genes and C2 Proteins |
|
|
284 | (1) |
|
Relatedness of Actin-ADP-Ribosylating Toxins with Other Toxins |
|
|
284 | (8) |
|
Relatedness with ADP-Ribosylating Toxins |
|
|
284 | (4) |
|
Relatedness with Bacillus anthracis Toxins |
|
|
288 | (1) |
|
|
288 | (1) |
|
Immunological Relatedness |
|
|
289 | (1) |
|
|
289 | (1) |
|
Relatedness with Other Binary Toxins |
|
|
290 | (1) |
|
|
290 | (1) |
|
|
291 | (1) |
|
Genetics of the Actin-ADP-Ribosylating Toxins |
|
|
292 | (2) |
|
|
292 | (1) |
|
|
293 | (1) |
|
|
294 | (3) |
|
Genes of Enzymatic and Binding-Component Genes are Organized in an Operon |
|
|
294 | (1) |
|
|
295 | (2) |
|
Identification of Actin-ADP-Ribosylating-Toxin-Producing Clostridia by Genetic Methods |
|
|
297 | (1) |
|
|
297 | (5) |
|
Enzymatic-Component Domains |
|
|
297 | (1) |
|
|
297 | (2) |
|
Enzymatic-Component Domain which Interacts with the Binding Component |
|
|
299 | (1) |
|
|
300 | (1) |
|
Binding-Component Domains |
|
|
300 | (2) |
|
|
302 | (5) |
|
|
302 | (5) |
|
Molecular Mechanisms of Action of the Large Clostridial Cytotoxins |
|
|
307 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
307 | (1) |
|
|
308 | (1) |
|
|
309 | (6) |
|
|
315 | (12) |
|
Elucidation of the Molecular Mechanism of Action |
|
|
315 | (1) |
|
|
316 | (1) |
|
|
316 | (2) |
|
Catalytic Domain and Requirements for Catalysis |
|
|
318 | (2) |
|
Recognition of the Protein Substrates |
|
|
320 | (1) |
|
Cellular Targets of the Cytotoxins |
|
|
321 | (1) |
|
Rho and Ras Proteins as Substrates |
|
|
321 | (1) |
|
|
321 | (1) |
|
Cellular Functions of Rho Proteins |
|
|
322 | (2) |
|
Functional Consequences of Glucosylation |
|
|
324 | (1) |
|
Consequences on the GTPase Cycle |
|
|
324 | (1) |
|
|
325 | (2) |
|
|
327 | (6) |
|
|
327 | (6) |
|
Molecular Biology of Large Clostridial Toxins |
|
|
333 | (28) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
333 | (2) |
|
Purification and Characterization of Large Clostridial Toxins |
|
|
335 | (6) |
|
|
335 | (1) |
|
Purification and Physicochemical Properties |
|
|
336 | (1) |
|
|
336 | (1) |
|
C. Sordellii and C. Novyi Toxins |
|
|
337 | (1) |
|
|
337 | (1) |
|
|
337 | (2) |
|
C. Sordellii and C. Novyi Toxins |
|
|
339 | (1) |
|
|
340 | (1) |
|
|
341 | (1) |
|
Molecular Genetics of the Toxins |
|
|
342 | (7) |
|
C. Difficile Toxin A and B Genes |
|
|
342 | (2) |
|
C. Difficile Toxigenic Element |
|
|
344 | (1) |
|
Atypical Strains of C. Difficile |
|
|
344 | (1) |
|
C. Sordellii and C. Novyi Genes |
|
|
345 | (1) |
|
Sequence Identity and Conserved Features of the Toxins |
|
|
346 | (1) |
|
N-Terminal Glucosyltransferase Domain |
|
|
346 | (1) |
|
|
347 | (1) |
|
Additional Conserved Features |
|
|
348 | (1) |
|
Gene Transfer in C. Difficile |
|
|
349 | (1) |
|
Regulation of C. Difficile Toxins |
|
|
349 | (2) |
|
|
351 | (10) |
|
|
351 | (10) |
|
The Cytotoxic Necrotizing Factor 1 from Escherichia Coli |
|
|
361 | (24) |
|
|
|
|
|
|
|
|
|
|
361 | (1) |
|
The CNF1 Gene and the Prevalence of CNF1-Producing Strains among Uropathogenic E. coli |
|
|
362 | (2) |
|
|
362 | (1) |
|
Prevalence of CNF1-Producing Strains among Uropathogenic E. coli |
|
|
363 | (1) |
|
Production, Purification and Cellular Effects of E. coli CNF1 |
|
|
364 | (1) |
|
Production and Purification of E. coli CNF1 |
|
|
364 | (1) |
|
Cellular Effects of E. coli CNF1 |
|
|
365 | (1) |
|
CNF1 Molecular Mechanism of Action |
|
|
365 | (8) |
|
Intracellular Enzymatic Activity of CNF1 |
|
|
365 | (3) |
|
Consequences of CNF1 Activity on Rho GTP-Binding Proteins |
|
|
368 | (5) |
|
Structure-Function Relationships of CNF1 and the Family of Dermonecrotic Toxins |
|
|
373 | (2) |
|
The C-Terminal Part of CNF1 Contains its Enzymatic Activity |
|
|
373 | (2) |
|
The N-Terminal Part of CNF1 Contains its Cell-Binding Activity |
|
|
375 | (1) |
|
Possible Roles for CNF1 as a Virulence Factor |
|
|
375 | (4) |
|
CNF1 and Induction of Phagocytosis |
|
|
375 | (2) |
|
|
377 | (1) |
|
CNF1: Epithelial Cell Permeability and PMN Trans-Epithelial Migration |
|
|
378 | (1) |
|
|
379 | (6) |
|
|
379 | (6) |
|
Shiga Toxins of Shigella dysenteriae and Escherichia coli |
|
|
385 | (22) |
|
|
|
|
|
|
|
|
|
Profile of the Shiga-Toxin Family |
|
|
385 | (4) |
|
|
385 | (1) |
|
|
386 | (1) |
|
Traits that Make the Members Part of a Family |
|
|
386 | (1) |
|
Characteristics that Distinguish Stx Family Members |
|
|
387 | (1) |
|
Role of Stxs in S. Dysenteriae Type 1 and STEC Disease |
|
|
388 | (1) |
|
Pathogenesis of Infection Caused by Organisms that Produce Stxs |
|
|
388 | (1) |
|
Associations Between Stxs and Development of HC and/or the HUS |
|
|
388 | (1) |
|
Findings with Animal and Tissue Culture Models that Support a Primary Role for Stxs in Virulence of Shiga's Bacillus and STEC |
|
|
389 | (1) |
|
Stx Genetics and Expression |
|
|
389 | (3) |
|
Location, Organization, and Nucleotide and Deduced Amino Acid Sequences of Stx Family Member Operons |
|
|
389 | (2) |
|
Regulation of Toxin Production |
|
|
391 | (1) |
|
|
391 | (1) |
|
Structure-Function Analyses of Stx Family Members |
|
|
392 | (4) |
|
|
392 | (1) |
|
Genetic Analyses of Stx Function |
|
|
393 | (3) |
|
Intracellular Trafficking of the Shiga Toxins |
|
|
396 | (1) |
|
Virulence/Toxicity Differences among the Stxs |
|
|
397 | (1) |
|
Immune Response to Stxs, Passive Anti-Stx Therapy, and Vaccine Development |
|
|
397 | (2) |
|
Anti-Toxin Responses during STEC Infection |
|
|
397 | (1) |
|
Passive Therapy with Anti-Stx Antibodies |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
399 | (8) |
|
|
399 | (8) |
|
|
407 | (38) |
|
|
|
|
|
|
|
|
|
|
407 | (2) |
|
Tetanus and Botulism in Man and Animals |
|
|
409 | (3) |
|
|
409 | (1) |
|
|
410 | (1) |
|
|
410 | (2) |
|
Structure of Clostridial Neurotoxins |
|
|
412 | (5) |
|
|
412 | (1) |
|
|
413 | (4) |
|
Toxicokinetics of Clostridial Neurotoxins |
|
|
417 | (5) |
|
Receptor Binding and Internalization |
|
|
417 | (2) |
|
Translocation from Endosomes into the Cytosol and Priming |
|
|
419 | (2) |
|
Sorting, Routing and Axonal Transport |
|
|
421 | (1) |
|
Toxicodynamics of Clostridial Neurotoxins |
|
|
422 | (5) |
|
Mode of Action of Clostridial Neuroproteases |
|
|
422 | (3) |
|
|
425 | (2) |
|
Clostridial Neurotoxins serve as Tools in Cell Biology and as Therapeutic Agents |
|
|
427 | (18) |
|
|
431 | (14) |
|
|
445 | (28) |
|
|
|
|
|
|
445 | (1) |
|
|
446 | (1) |
|
Gene Location and Organization |
|
|
446 | (1) |
|
DNA Sequences and Transcriptional Regulation |
|
|
446 | (1) |
|
|
447 | (9) |
|
Toxin Production, Purification, and Properties |
|
|
447 | (1) |
|
PA Structure and Function |
|
|
448 | (4) |
|
LF Structure and Function |
|
|
452 | (2) |
|
EF Structure and Function |
|
|
454 | (1) |
|
|
455 | (1) |
|
Cellular Uptake and Internalization |
|
|
456 | (6) |
|
|
456 | (1) |
|
Proteolytic Activation of PA |
|
|
456 | (1) |
|
LF and EF Binding to PA63 |
|
|
457 | (1) |
|
|
458 | (1) |
|
|
459 | (2) |
|
Translocation and Cytosolic Trafficking |
|
|
461 | (1) |
|
|
462 | (2) |
|
|
462 | (1) |
|
|
463 | (1) |
|
Therapeutic Applications of LF Fusion Proteins |
|
|
464 | (1) |
|
Summary and Future Prospects |
|
|
465 | (8) |
|
|
465 | (8) |
|
Adenylyl-Cyclase Toxin from Bordetella pertussis |
|
|
473 | (16) |
|
|
|
|
|
|
|
|
|
Introduction and Background |
|
|
473 | (1) |
|
Gene and Protein Structure |
|
|
474 | (1) |
|
Biological Activities of AC Toxin |
|
|
475 | (5) |
|
|
475 | (1) |
|
|
476 | (1) |
|
Pore Formation and Hemolysis |
|
|
477 | (2) |
|
|
479 | (1) |
|
Possible Role/s for AC Toxin in Pathogenesis |
|
|
480 | (1) |
|
AC toxin as a Protective Antigen |
|
|
481 | (1) |
|
Uses of AC Toxin as a Novel Research Reagent |
|
|
482 | (1) |
|
|
482 | (7) |
|
|
483 | (6) |
|
Helicobacter Pylori Vacuolating Cytotoxin |
|
|
489 | (20) |
|
|
|
|
|
|
|
|
|
|
489 | (1) |
|
Identification and Purification of the H. pylori Vacuolating Cytotoxin |
|
|
490 | (1) |
|
Gene Structure and Mechanism of Secretion |
|
|
491 | (4) |
|
Cloning and Molecular Characterisation of vacA Encoding the Vacuolating Cytotoxin |
|
|
491 | (2) |
|
Autotransporter Organisation of the VacA Precursor |
|
|
493 | (1) |
|
Mosaic Gene Structure of vacA Alleles in the H. pylori Population |
|
|
493 | (1) |
|
Consequences of the vacA Mosaic Gene Structure |
|
|
494 | (1) |
|
Presence of vacA Homologues in the H. pylori Genome |
|
|
494 | (1) |
|
Regulation of vacA Gene Expression |
|
|
495 | (1) |
|
Extracellular Structure and Activation of the Vacuolating Cytotoxin |
|
|
496 | (1) |
|
Processing and Quaternary Structure |
|
|
496 | (1) |
|
|
496 | (1) |
|
Effects of VacA on Eucaryotic Cells |
|
|
497 | (5) |
|
Binding to Target Cells and Mechanism of Uptake |
|
|
497 | (2) |
|
|
499 | (2) |
|
|
501 | (1) |
|
Clinical Relevance of the Vacuolating Cytotoxin |
|
|
502 | (1) |
|
VacA as a Vaccine Candidate |
|
|
503 | (1) |
|
|
503 | (6) |
|
|
504 | (5) |
|
|
509 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Occurrence and Biological Significance |
|
|
509 | (1) |
|
Purification and Properties of Monomeric Toxin |
|
|
509 | (1) |
|
|
510 | (2) |
|
|
510 | (1) |
|
|
511 | (1) |
|
|
512 | (1) |
|
Structure of Oligomeric Pores |
|
|
512 | (5) |
|
Structure of the Heptameric Pore Formed in Detergent Solution |
|
|
512 | (2) |
|
Structure of the Membrane-Bound Oligomer |
|
|
514 | (3) |
|
|
517 | (3) |
|
|
517 | (1) |
|
Secondary Cellular Reactions |
|
|
517 | (1) |
|
Reactions Provoked by Transmembrane Flux of Monovalent Ions |
|
|
517 | (1) |
|
|
518 | (2) |
|
Long-Range Effects of α Toxin |
|
|
520 | (1) |
|
Synergism Between α Toxin and Other Toxins |
|
|
520 | (1) |
|
Resistance and Repair Mechanism |
|
|
520 | (2) |
|
Use of α Toxin in Cell Biology |
|
|
522 | (1) |
|
Medical Relevance of α Toxin |
|
|
523 | (6) |
|
|
524 | (5) |
|
|
529 | (28) |
|
|
|
|
|
|
|
|
|
|
529 | (1) |
|
Related Groups of Phospholipases |
|
|
529 | (7) |
|
Zinc Metallophospholipase Cs |
|
|
530 | (5) |
|
|
535 | (1) |
|
Phosphatidylinositol PLCs |
|
|
535 | (1) |
|
|
536 | (1) |
|
Functional and Biological Properties of Phospholipases |
|
|
536 | (2) |
|
Modulation of Eukaryotic Cell Metabolism |
|
|
538 | (4) |
|
Hydrolysis of Membrane Phospholipids |
|
|
538 | (3) |
|
Hydrolysis of Membrane Phospholipids Modulates Cell Metabolism |
|
|
541 | (1) |
|
|
542 | (2) |
|
Regulation of the C. perfringens plc gene |
|
|
542 | (1) |
|
Environmental Control of PLC Production in P. aeruginosa |
|
|
542 | (1) |
|
Regulation of the Listeria Phospholipases by PrfA |
|
|
543 | (1) |
|
|
544 | (4) |
|
|
544 | (2) |
|
|
546 | (1) |
|
The Pathogenesis of Listeriosis |
|
|
547 | (1) |
|
Caseous Lymphadenitis in Ruminants |
|
|
548 | (1) |
|
|
548 | (9) |
|
|
549 | (8) |
|
Pore-Forming Toxins as Cell-Biological and Pharmacological Tools |
|
|
557 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Permeabilized Cells: an Approach to the Study of Intracellular Processes |
|
|
557 | (2) |
|
α-Toxin and SLO as Tools with which to Study Functional Aspects of Intracellular Organelles |
|
|
559 | (13) |
|
Biological Activity and Cell Permeability |
|
|
559 | (1) |
|
Protocol 1: Permeabilization of Attached Cells by α-Toxin or SLO |
|
|
560 | (1) |
|
|
560 | (1) |
|
Protocol 2: Permeabilization of Cells in Suspension |
|
|
560 | (1) |
|
Commentary for Protocols 1 and 2 |
|
|
561 | (1) |
|
Protocol 3: Assay to Compare Biological Activity of Various Pore-Forming Toxins Using Rabbit Erythrocytes |
|
|
561 | (1) |
|
Commentary for Protocol 3 |
|
|
562 | (1) |
|
Protocol 4: Trypan-Blue Exclusion Test |
|
|
562 | (1) |
|
Commentary for Protocol 4 |
|
|
563 | (1) |
|
Introduction of Membrane Impermeable Proteins |
|
|
563 | (2) |
|
Protocol 5: Introduction of Membrane-Impermeable Proteins. Immunofluorescence for Synaptophysin |
|
|
565 | (1) |
|
Commentary for Protocol 5 |
|
|
565 | (1) |
|
Protocol 6: Introduction of Membrane-Impermeable Proteins. TeNT/LC |
|
|
566 | (1) |
|
Commentary for Protocol 6 |
|
|
567 | (1) |
|
Assay for Exocytosis in Permeabilized Cells |
|
|
567 | (1) |
|
Protocol 7: Measuring Exocytosis in Permeabilized Suspension Cells |
|
|
568 | (2) |
|
Protocol 8: Measuring Exocytosis in Permeabilized Attached Cells |
|
|
570 | (1) |
|
Commentary for Basic Protocols 7 and 8 |
|
|
570 | (1) |
|
Regulation of Vesicular Transmitter Transporters in Permeabilized Cells |
|
|
570 | (1) |
|
Protocol 9: Regulation of Vesicular Transmitter Transporters in Permeabilized Cells |
|
|
571 | (1) |
|
Commentary for Basic Protocol 9 |
|
|
572 | (1) |
|
Chemicals Used in the Protocols |
|
|
572 | (1) |
|
|
573 | (4) |
|
|
573 | (4) |
|
Heat-Stable Enterotoxin of Escherichia Coli |
|
|
577 | (18) |
|
|
|
|
|
|
|
|
|
|
577 | (1) |
|
Heat-Stable Enterotoxin STa |
|
|
578 | (7) |
|
Structure and Biological Properties of STa |
|
|
578 | (2) |
|
|
580 | (5) |
|
STa-Like Heat-Stable Enterotoxin |
|
|
585 | (1) |
|
Heat-Stable Enterotoxin STb |
|
|
585 | (3) |
|
|
585 | (1) |
|
Biological Function of STb |
|
|
586 | (2) |
|
|
588 | (7) |
|
|
588 | (7) |
|
|
595 | (24) |
|
|
|
|
|
|
595 | (1) |
|
|
595 | (1) |
|
PETs of S. Aureus and S. Pyogenes |
|
|
596 | (11) |
|
|
596 | (4) |
|
Molecular Mechanism of Action |
|
|
600 | (1) |
|
Binding to MHC class-II Molecules |
|
|
600 | (1) |
|
|
601 | (1) |
|
|
602 | (2) |
|
Biological Significance of PETs |
|
|
604 | (1) |
|
Role of PETs as Virulence Factors |
|
|
604 | (1) |
|
|
604 | (1) |
|
Association with Human Autoimmune Disease |
|
|
605 | (1) |
|
|
606 | (1) |
|
Other Superantigens (or Pseudosuperantigens) of Gram-Positive Cocci? |
|
|
607 | (3) |
|
|
607 | (1) |
|
M Proteins and SPE B of S. Pyogenes |
|
|
607 | (1) |
|
The Mitogenic Factor of S. Pyogenes |
|
|
608 | (2) |
|
The M. Arthritidis Superantigen |
|
|
610 | (1) |
|
The Y. Pseudotuberculosis Mitogen |
|
|
610 | (1) |
|
|
611 | (8) |
|
|
611 | (8) |
|
Structure and Activity of Endotoxins |
|
|
619 | (50) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
619 | (5) |
|
The Chemical Structure of LPS |
|
|
624 | (8) |
|
Structural Characteristics of the O-Specific Chain |
|
|
627 | (1) |
|
Structural Characteristics of the LPS Core |
|
|
627 | (2) |
|
Structural Characteristics of Lipid A |
|
|
629 | (3) |
|
|
632 | (2) |
|
|
632 | (1) |
|
Biosynthesis of the Core Region |
|
|
632 | (1) |
|
Biosynthesis of the O-Specific Chain |
|
|
633 | (1) |
|
Structure-Activity Relationships of LPS and Lipid A |
|
|
634 | (2) |
|
Cellular and Humoral Responses to LPS in Mammals |
|
|
636 | (8) |
|
Strategies for the Treatment of Gram-Negative Infections |
|
|
644 | (7) |
|
|
645 | (2) |
|
Antagonists of Endotoxic Effects |
|
|
647 | (2) |
|
Neutralizing Antibodies Against Endotoxin |
|
|
649 | (2) |
|
|
651 | (18) |
|
|
652 | (17) |
|
Translocated Toxins and Modulins of Yersinia |
|
|
669 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
669 | (1) |
|
Yersinia Protein Type-III Secretion/Translocation System |
|
|
670 | (4) |
|
|
670 | (1) |
|
Regulation of Yop Expression, Secretion and Translocation |
|
|
671 | (3) |
|
Translocated Toxins and Modulins of Yersinia (Effector Yops) |
|
|
674 | (9) |
|
YopH, a Highly Active Tyrosine Phosphatase |
|
|
674 | (3) |
|
YopE, an Actin-Disrupting Cytotoxin |
|
|
677 | (1) |
|
YopP, Modulator of Multiple Signal Pathways Leading to Apoptosis and Cytokine Suppression |
|
|
678 | (3) |
|
YopT, Another Actin-Disrupting Cytotoxin |
|
|
681 | (1) |
|
YopM-So Far, no Evidence for an Intracellular Function |
|
|
681 | (1) |
|
YpkA, a Putative Serine/Threonine Kinase Affecting Cell Shape |
|
|
682 | (1) |
|
|
683 | (8) |
|
|
685 | (6) |
Subject Index |
|
691 | |